港股早評:恆指高開0.13% 生物醫藥股走高 華盛國際復牌漲超131%
格隆匯1月10日丨港股開盤漲跌不一,恆指漲0.13%,國指跌0.01%,恆生科技指數跌0.07%。盤面上,科技股繼續反彈,騰訊、網易漲超1%,百度、快手小幅高開,生物醫藥股走高,沛嘉醫療大漲近10%,石藥集團漲2.5%,內房股與物管股普漲,連續回調的電力股反彈,龍源電力漲近3%;體育用品股、燃氣股、石油股下跌明顯,滔搏跌超2%,公司董事長王濱被查,中國人壽低開近2%;華盛國際控股復牌漲超131%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.